139 related articles for article (PubMed ID: 16176353)
21. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Wang SJ; Wang KY; Wang WC; Sihra TS
J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
[TBL] [Abstract][Full Text] [Related]
22. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
23. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
[TBL] [Abstract][Full Text] [Related]
24. Individual and additive effects of neuromodulators on the slow components of afterhyperpolarization currents in layer V pyramidal cells of the rat medial prefrontal cortex.
Satake T; Mitani H; Nakagome K; Kaneko K
Brain Res; 2008 Sep; 1229():47-60. PubMed ID: 18634769
[TBL] [Abstract][Full Text] [Related]
25. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
27. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
28. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.
Moha ou Maati H; Bourcier-Lucas C; Veyssiere J; Kanzari A; Heurteaux C; Borsotto M; Haddjeri N; Lucas G
Brain Struct Funct; 2016 Jan; 221(1):21-37. PubMed ID: 25233810
[TBL] [Abstract][Full Text] [Related]
29. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Arvanov VL; Wang RY
Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
[TBL] [Abstract][Full Text] [Related]
30. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.
Boothman LJ; Allers KA; Rasmussen K; Sharp T
Br J Pharmacol; 2003 Jul; 139(5):998-1004. PubMed ID: 12839874
[TBL] [Abstract][Full Text] [Related]
31. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
Ceglia I; Carli M; Baviera M; Renoldi G; Calcagno E; Invernizzi RW
J Neurochem; 2004 Oct; 91(1):189-99. PubMed ID: 15379899
[TBL] [Abstract][Full Text] [Related]
32. Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.
Benekareddy M; Goodfellow NM; Lambe EK; Vaidya VA
J Neurosci; 2010 Sep; 30(36):12138-50. PubMed ID: 20826676
[TBL] [Abstract][Full Text] [Related]
33. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
Jennings KA; Sheward WJ; Harmar AJ; Sharp T
Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894
[TBL] [Abstract][Full Text] [Related]
34. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
[TBL] [Abstract][Full Text] [Related]
35. Endogenous activation of serotonin-2A receptors is required for respiratory rhythm generation in vitro.
Peña F; Ramirez JM
J Neurosci; 2002 Dec; 22(24):11055-64. PubMed ID: 12486201
[TBL] [Abstract][Full Text] [Related]
36. Stress impairs 5-HT2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala.
Jiang X; Xing G; Yang C; Verma A; Zhang L; Li H
Neuropsychopharmacology; 2009 Jan; 34(2):410-23. PubMed ID: 18536707
[TBL] [Abstract][Full Text] [Related]
37. Activity-dependent serotonergic excitation of callosal projection neurons in the mouse prefrontal cortex.
Stephens EK; Avesar D; Gulledge AT
Front Neural Circuits; 2014; 8():97. PubMed ID: 25206322
[TBL] [Abstract][Full Text] [Related]
38. 5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization.
Edwards E; Hampton E; Ashby CR; Zhang J; Wang RY
Brain Res; 1996 Sep; 733(1):21-30. PubMed ID: 8891244
[TBL] [Abstract][Full Text] [Related]
39. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
40. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
Carli M; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
